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Abstract
Differential equation models that describe the dynamic changes of biochemical signaling states are important tools to
understand cellular behavior. An essential task in building such representations is to infer the affinities, rate constants, and
other parameters of a model from actual measurement data. However, intuitive measurement protocols often fail to
generate data that restrict the range of possible parameter values. Here we utilized a numerical method to iteratively design
optimal live-cell fluorescence microscopy experiments in order to reveal pharmacological and kinetic parameters of a
phosphatidylinositol 3,4,5-trisphosphate (PIP3) second messenger signaling process that is deregulated in many tumors. The
experimental approach included the activation of endogenous phosphoinositide 3-kinase (PI3K) by chemically induced
recruitment of a regulatory peptide, reversible inhibition of PI3K using a kinase inhibitor, and monitoring of the PI3K-
mediated production of PIP3 lipids using the pleckstrin homology (PH) domain of Akt. We found that an intuitively planned
and established experimental protocol did not yield data from which relevant parameters could be inferred. Starting from a
set of poorly defined model parameters derived from the intuitively planned experiment, we calculated concentration-time
profiles for both the inducing and the inhibitory compound that would minimize the predicted uncertainty of parameter
estimates. Two cycles of optimization and experimentation were sufficient to narrowly confine the model parameters, with
the mean variance of estimates dropping more than sixty-fold. Thus, optimal experimental design proved to be a powerful
strategy to minimize the number of experiments needed to infer biological parameters from a cell signaling assay.
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Introduction
Biological cells continuously process stimuli that they receive
from their inside and outside, using interconnected signaling
pathways. Since strength, timing, and combination of inputs
typically determine the output behavior in a non-linear manner,
dynamic models of such signaling networks in the form of
differential equations are becoming widely used to complement
experimental studies [1,2]. A major challenge to systems biology is
therefore, to infer the rate constants, binding affinities and other
parameters of such models from actual measurement data [3,4].
Parameter estimation is a widely applied method for model
calibration in mechanical and chemical engineering, and — if
transferred to the field of cell signaling — may facilitate the
development of predictive models of disease and therapy [5].
However, because measurements are always afflicted with error,
parameter estimates which minimize the discrepancy between
model and data often come along with high uncertainty.
Gutenkunst et al. [6] studied parameter sensitivities in 17 published
models in the field of systems biology, and concluded that
parameter estimation in biology is difficult not only because of
often large measurement error, but also because model behavior is
often insensitive to combined changes of parameter values. The
resulting working models thus remain limited in mechanistic
insight and in their capability to predict system dynamics in
unforeseen conditions.
For a given set of differential equations that describes a dynamic
process, not every experimental protocol is equally suited to
produce data from which parameters can be inferred. However, it
is often possible to control a dynamic process in such a way that
predicted measurements are very sensitive to the parameter values
that underlie the dynamic system. In that case, the data would be
better suited for parameter estimation because it restricts the range
of parameter values that could explain the data. To efficiently
determine experimental protocols that sensitize model predictions
to parameter values, optimal control problems need to be solved.
Ko ¨rkel et al. [7,8] developed and implemented an efficient scheme
for solving such optimal control problems in chemical engineering,
given deterministic models in the form of ordinary differential
equations (ODE) or differential algebraic equations (DAE). These
solutions propose how to best feed a reactor, control its
temperature, and when to take measurements in order to estimate
parameters with highest accuracy, while obeying constraints
imposed by feasibility or cost. Although the computed experimen-
PLoS Computational Biology | www.ploscompbiol.org 1 November 2009 | Volume 5 | Issue 11 | e1000558tal protocols and sampling schemes are unavoidably based only on
approximate models and parameter values, experience shows that
data evaluated from optimized experiments are typically more
informative than data from intuitively planned experiments[8]. By
designing experiments sequentially, the iterative process of
performing experiments can be paralleled by an increasing
predictive power to plan the next experiment.
Several computational studies on models of the MAP kinase
cascade, apoptosis, STAT5 activation, and the NF{kB pathway
[9–14] suggested that this strategy could also be valuable for the
experiment-driven modeling of signal transduction networks.
These studies showed that given a specific model of a biological
process, several numerical methods can be used to identify
stimulus and sampling patterns that would reveal parameter values
with higher accuracy. The practical value of such an approach
could be immense, because experiments are sensitized to reveal
otherwise hidden biological parameters. However, despite a
wealth of diverse numerical approaches [8,9,11,13,15] (reviewed
in [16]), those methods have not been adopted by experimental-
ists. The theoretical nature of previous work left it unclear,
whether optimized experiments would drive a true biological
system within the predictive range of a model [15], how
experimental uncertainty and imperfection affect the attainable
accuracy of estimates, and how design performance is affected by
the possibly large discrepancy between true biology and a
differential equations model. Moreover, the increased complexity
of proposed stimulus designs has raised the question whether
numerically optimized experiments are even feasible enough to
return net savings of experimental effort in a real-world cell
biology lab.
Here, we addressed these questions explicitly by employing a
numerical approach to enrich an existing single-cell assay for
pharmacologically, biochemically, and clinically relevant param-
eters by an optimized protocol. Our study focused on the
accumulation of the phosphatidylinositol 3,4,5-trisphosphate
(PIP3) second messenger lipid and the subsequent recruitment of
downstream signaling elements through pleckstrin homology (PH)
domains. PIP3 is produced by the catalytic subunit p110 of
phosphoinositide 3-kinase (PI3K) in response to chemokine or
other receptor stimuli in the plasma membrane of eukaryotic cells.
Slow diffusion and rapid degradation of PIP3 result in gradients
that are steep enough to mediate cell polarity as in migration and
differentiation, but elevated synthesis of PIP3 is associated with
cancer. Signaling elements downstream of PI3K, like the
oncogenic Akt protein, engage by binding to PIP3-enriched
membranes through pleckstrin homology (PH) domains. Previ-
ously, Suh et al. [17] described a chemical method for activating
endogenous p110 at the plasma membrane. This technique makes
use of the rapamycin-dependent heterodimerization of the FK506-
binding protein (FKBP) with the mammalian target of rapamycin
(mTOR). A genetic fusion of cyan fluorescent protein (CFP),
FKBP12, and a peptide from the regulatory subunit p85 of PI3K
was constructed (CF-p85) that resides in the cytosol and does not
intrinsically stimulate p110 activity. However, upon addition of the
rapamycin derivative iRap to cells co-transfected with a construct
made from the N-terminal plasma membrane-targeting sequence
of Lyn and the FKBP-rapamycin binding domain of mTOR (Lyn-
FRB), CF-p85 translocates to the plasma membrane and induces
the production of PIP3 (Figure 1A). Elevated concentrations of
PIP3 can be monitored through translocation events of a construct
in which yellow fluorescent protein is fused to the PH-domain of
Akt (Y-PH).
Our experimental setup observed translocation dynamics of CF-
p85 and Y-PH in NIH 3T3 fibroblasts by live-cell confocal
fluorescence microscopy in order to infer the kinetic parameters of
the underlying dynamic system. If such parameters were inferable
with high statistical confidence, it would be possible, for example,
to compare the inhibitory effects of different cancer drug
candidates on PI3K directly and in situ. To shed light on nonlinear
signal transmission, it would be desirable also to reveal differential
affinities of the more than 20 PH domains that were shown to be
PIP3 responsive [18]. Moreover, the degradation of PIP3 is
compromised in many tumors, whereas in others, sustained
growth factor inputs could be responsible for elevated downstream
signaling. We asked if the established single-cell assay would yield
dynamic data from which such relevant properties could be
inferred by fitting a differential equations model. However, we
found that our intuitively planned and often used experimental
protocol was not informative about these parameters. Even for a
simplified model, the parameter estimates were largely undefined
and covaried strongly. Since the traditional experimental protocol
involved two drugs, iRap and the PI3K inhibitor LY294002
(LY29), we utilized a numerical optimization method [7,8] to
design better concentration-time profiles for these drugs in order
to reveal model parameters with higher accuracy. We performed
these numerically optimized experiments sequentially, and found
that the uncertainty of parameter estimates could be reduced
dramatically and covariance be largely eliminated. Given the
potential implications on systems biology methodology, the paper
derives meaningful constraints of the optimization problem as it
pertains to live-cell experimentation, and investigates the implica-
tions of experimental uncertainty and imperfection.
Results
NIH 3T3 fibroblasts were transfected with three constructs, (i) a
plasma membrane-targeted FRB domain (Lyn-FRB), (ii) an
inducible PI3K-activating peptide derived from p85 and conju-
gated to an FKBP12 domain and CFP (CF-p85), and (iii) a YFP-
conjugated PH domain from Akt as a biosensor for PIP3 (Y-PH).
Because growth factors present in serum already activate PI3K,
Author Summary
Differential equation models of signaling processes are
useful to gain a molecular and quantitative understanding
of cellular information flow. Although these models are
typically based on simple kinetic rules, they can often
qualitatively describe the behavior of biological systems.
However, in the quest to transform biomedical research
into an engineering discipline, biologists face the chal-
lenge of estimating important parameters of such models
from laboratory data. Measurement noise as well as the
robust architecture of biological circuits are causes for
large uncertainty of parameter estimates. This makes it
difficult to plan informative experiments. Here, we used a
computational method to predict and minimize the
uncertainty of parameter estimates we would obtain from
prospective experiments given a cancer-relevant signaling
model. This was achieved by optimizing the concentra-
tions and time points for adding drugs in a live-cell
microscopy experiment. Our experimental results demon-
strated that the advice given by this algorithm resulted in
many-fold more informative data than we would obtain by
repeating an intuitively planned experiment. Our study
shows that significant experimental effort and time can
be saved by adopting an optimal experimental design
strategy for inferring relevant parameters from biomedical
experiments.
Optimal Experimental Design
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confocal fluorescence microscopy. Throughout the first 5 min of
imaging, the cells were not perturbed, and both CF-p85 and Y-PH
resided in the cytosol (Figure 1B and Video S1). After addition of
1 mM iRap, CF-p85 rapidly translocated to the plasma mem-
brane, closely followed by Y-PH. The translocation of these
constructs indicates that iRap-mediated heterodimerization of the
FRB and FKBP12 domains recruits the p85-derived peptide to the
plasma membrane where it triggers PI3K to produce PIP3. The
accumulation of PIP3 in turn traps Y-PH at the plasma
membrane, as indicated by a decline in cytosolic fluorescence.
Ten minutes after the addition of iRap, the production of PIP3
Figure 1. Parameter estimation of PI3K signaling reveals identifiability problems for important kinetic properties. (A) iRap-induced
dimerization of FKBP with FRB recruits CF-p85 to the plasma membrane and activates the catalytic subunit p110 of PI3K to produce PIP3 from PIP2.
PH domains of many downstream signaling proteins bind to PIP3 enriched membranes with differential affinities. LY29 is a widely used inhibitor of
PI3K. (B) Confocal fluorescence images of an NIH 3T3 cell (CF-p85 shown in cyan, Y-PH in yellow). Initially, CF-p85 and Y-PH reside in the cytosol (left).
Addition of iRap recruits both constructs to the plasma membrane as can be judged from cytosolic depletion (middle). Y-PH but not CF-p85
dissociates from the plasma membrane upon addition of LY29. Experiment time is shown in minutes. (C) Differential equations model of the dynamic
system illustrated in (A). System parameters are shown in blue, variables that allow control of the system are shown in green, and calibration
parameters which were different from cell to cell are shown in gold. (D) Parameter values can be inferred by minimizing the discrepancy between
model and experimental data. The schematic illustrates this concept for two parameters, pi and pj. The range of possible parameter values is where
this discrepancy falls below the confidence level (blue shaded ellipsoid). If this range is large, parameters can be inferred only with high uncertainty.
(E) Fluorescence was quantified in the green square depicted in (B), and the model in (C) was fit to that data. Error bars show data, continuous lines
show model output. Blue error bars and lines show cytosolic fluorescence of CF-p85, orange error bars and lines cytosolic fluorescence of Y-PH. (F)
The relative uncertainty of parameter estimates was very high. This is a common problem in systems biology models. (G) Schematic projection of the
confidence ellipsoid from (D). Good experiments minimize the size of this uncertainty region (shaded blue). Criteria that have been proposed for
describing this size are the longest half-axis, the average extent, or the volume of the confidence ellipsoid, among others. These criteria correspond to
properties of the parameter covariance matrix C.
doi:10.1371/journal.pcbi.1000558.g001
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immediately started to dissociate from the plasma membrane and
a marked increase in cytosolic fluorescence of Y-PH was observed,
suggesting rapid turnover of PIP3.
Inferring kinetic and pharmacological properties from
single-cell data
In order to infer biological parameters from the observed
translocation dynamics, we set up a differential equations model
(Figure 1C, Text S1) that reflects this system. It is a system of
ordinary differential equations (ODE) of the form
dx t ðÞ
dt
~fxt ðÞ ,p,ut ðÞ ðÞ : ð1Þ
It comprises differential states xt ðÞ for the amounts of PIP3
( PIP3 ½  ), of CF-p85 bound to iRap ( iRap::p85 ½  ), of CF-p85 in a
ternary complex with Lyn-FRB via iRap ( Lyn::iRap::p85 ½  ) and
of Y-PH bound to the plasma membrane ( PH ½  mem). All other
molecular species were derived from total amounts via mass
balance. The parameters p of this model are the rate constant w for
the degradation of PIP3, the inhibitor constant KLY for the effect
of LY29 on p110, the rate constants kr and kt for the stepwise
formation of the ternary complex, ka for the attachment of Y-PH
to PIP3-enriched membranes, and a for its dissociation (Figure 1C,
blue). This simplified model assumes that the formation of the
complex of CF-p85, iRap, and Lyn-FRB begins with the binding
of iRap to CF-p85 [19], that both this reaction and the subsequent
binding of Lyn-FRB are irreversible, and that Y-PH does not
shield PIP3 from degradation. Because the amounts of the
exogenously expressed CF-p85, Lyn-FRB, and Y-PH vary from
experiment to experiment i, the total amount of each of those
species p85 ½  tot,i, Lyn ½  tot,i, and PH ½  tot,i were additional model
parameters that solely served the purpose of calibration (Figure 1C,
gold). The time-dependent concentrations of iRap and LY29 were
represented as piecewise constant functions ui,k t ðÞstepping from
0t o1mM at 5 min for iRap, and from 0t o2 5mM for LY29
10 min later:
iRap ½  ~u1,1 t ðÞ ~
0 : tv5 min
1 mM : otherwise
 
, ð2Þ
LY29 ½  ~u1,2 t ðÞ ~
0 : tv15 min
25 mM : otherwise
 
, ð3Þ
where ui,k t ðÞdenotes the concentration of the respective drug k in
experiment i at time t (Figure 1C, green).
The cytosolic fluorescence intensities of CF-p85 and Y-PH were
measured for a single cell from 25 frames captured every minute.
In order to relate the measured values gj from frame j to a
cytosolic concentration in the model at time tj, the observation
functions
hYFP xt j;p,u
  
,p
  
~ PH ½  tot{ PH ½  mem tj
  
ð4Þ
hCFP xt j;p,u
  
,p
  
~ p85 ½  tot{ Lyn :: iRap :: p85 ½  tj
  
ð5Þ
were defined. Using these observation functions, the model can be
fitted to the two fluorescence trajectories by finding a parameter
set p that minimizes a weighted least squares functional:
min
p
X 25
j~1
gYFP, j{hYFP xt j;p,u
  
,p
      2
s2
YFP,j
z
gCFP, j{hCFP xt j;p,u
  
,p
      2
s2
CFP,j
 !
: ð6Þ
The measurement errors sj were estimated from individual frames
(see Methods). For collective fits from N independent experiments
i, the least squares functional is a sum over i of the above
expression (6).
Figure 1D shows a schematic of the parameter estimation
concept. For the experimental treatment described by u, the model
predicts observations ht j;p
  
that should coincide — within the
range of measurement error — with data gj. If the predicted
observations depend on the model parameters p, it is possible to
infer the parameter set that minimizes the discrepancy between
model and data. If this discrepancy falls below the confidence level
which is defined by the measurement errors sj, the model is
considered a ‘‘fit’’. To infer parameter values from microscopy
experiments, i.e. to minimize expression (6), a multiple shooting
Gauss-Newton type algorithm was employed (see Methods). The
resulting parameter set yielded good agreement between model
and data (Figure 1E).
However, the behavior of biological systems is often robust to
changes in rate constants, binding affinities, and concentrations.
Thus, large regions in parameter space often correspond to
similarly good model predictions, and therefore, it is often not
possible to infer parameter values from experimental data with
satisfying precision [6]. Figure 1D depicts this uncertainty region
as the area where the least squares functional falls below the
confidence level hyperplane (blue shaded region). In other words,
the uncertainty of parameter estimates is inversely related to the
sensitivity of testable model predictions h to changes in parameter
values p:
J~{S{1 dh
dp
ð7Þ
where S is the matrix of diagonalized sj and h are the vectorized
predictions hxt j;p,u
  
,p
  
of the ODE model. From these
sensitivities, the parameter covariance matrix C~ JTJ ðÞ
{1 can
be obtained. Note that the covariance matrix C depends on the
experimental protocol u. C describes the uncertainty region in
parameter space in proximity of the solution p of the estimation
problem. In particular, the nth diagonal element of this matrix
approximates the variance Varn of a specific parameter estimate
pn. For the initial fit shown in Figure 1E, the relative uncertainties ﬃﬃﬃﬃﬃﬃﬃﬃ
Var
p  
p indicate that the intuitive experimental protocol is not
very suitable to define the parameters of interest (Figure 1F,
Table 1).
Optimal experimental design for parameter estimation
In order to maximize the information gained about kinetic and
pharmacological properties, we asked if we could find a second
experimental protocol u2,k t ðÞ with given u1,k t ðÞ that would
minimize the predicted parameter variances from a collective fit.
Such a minimum would correspond to a smaller confidence region
(shaded blue in Figure 1D). Figure 1G shows the ellipsoid
approximation of this confidence region for a case with two
parameters. Different geometric properties of this confidence
ellipsoid correspond to properties of the covariance matrix C.W e
chose to minimize the mean of the diagonal elements (the trace of
C divided by the number of parameters) to balance the
experimental effort between parameters. We would like to note
that several other properties of C have been proposed as design
(6)
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to minimizing the volume of the uncertainty region, whereas
minimizing the maximum eigenvalue (max l) corresponds to
minimizing the longest half-axis (Figure 1G).
Using the trace criterion, the second experimental design u2,k t ðÞ
was optimized with the previous experiment u1,k t ðÞincluded in the
prediction of C and based on the current parameter estimates.
ui,k t ðÞwere piecewise constant functions that were discretized into
three intervals. This means that the composition of extracellular
buffer was allowed to change twice at 5 and 15 min with
measurements taken every minute for 24 min. The maximum
concentrations of drug allowed were 1 mM for iRap or 25 mM for
LY29. The traditional experimental protocol served as an initial
design that was optimized by a numerical method that employs in
its core a sequential quadratic programming (SQP) method [20]
(see Methods). SQP is an efficient derivative-based local optimi-
zation method that approaches the Karush-Kuhn-Tucker condi-
tions (local optimality conditions) iteratively. It is particularly
suited for large optimization problems with many design variables
such as drug concentrations. How good a local minimum is
approximated by an SQP run depends on termination critera.
Typically, good improvements of the initial design can be observed
in practice (see for example [8]). Here, we obtained from a single
SQP run an experimental protocol (Figure 2A) for which the mean
of variances was predicted to be more than 50-fold reduced when
compared to a repetition of the established protocol. The numer-
ically optimized protocol suggested that we add a low dose of iRap
for the first 5 min. Then, the concentration of iRap should be
increased to 1 mM in the presence of 8:7 mM LY29 for the next
10 min. Finally, LY29 should be washed out in the presence of
iRap (Figure 2B). While in general, the predicted improvement
of parameter estimates is subject to parameter and model
uncertainty, the predicted gain of information appeared promising
(Figure 2C, blue arrows).
Figure 2D shows confocal microscopy images from the
realization of this numerically optimized experiment. Translocation
of CF-p85 was induced submaximally using 30 nM iRap for 5 min,
but was then reinforced by the addition of 1 mM iRap in the
presence of 8:7 mM LY29. The addition of 1 mM iRap induced
rapid translocation of CF-p85 while Y-PH remained cytosolic due
to the inhibitory effect of LY29 on PI3K. Ten minutes later, LY29
was washed out with extracellular buffer containing 1 mM iRap.
The buffer exchange of most of the solution occurred in less than
one minute by making use of combined addition of buffer and
vacuum suction (Figure 2B). Immediately after the washout of
LY29, Y-PH started to translocate to the plasma membrane,
indicating that the production of PIP3 resumed (see also Video S2).
Uncertainty in biological experimentation
The experiment illustrates an important problem that arises
often from numerical optimization of biological experiments, in
that these experiments are often challenging and introduce
additional uncertainty. For example, the withdrawal of a growth
factor stimulus may only partially reduce signaling due to tight
receptor binding. Similarly, the knock-down of a protein by siRNA
is never complete, and the magnitude of reduction in protein
expression may vary from cell to cell. In this particular case, it was
conceivable that some LY29 remained in the imaging chamber
after the washout. While such experimental uncertainties are often
irrelevant to traditional biology, the implications on parameter
estimation from biological data can be significant. Thus, the
implications of experimental imperfection on the performance of
numerically optimized and idealized experiments need to be
addressed.
In this specific case, we accounted for experimental uncertainty
by estimating the residual concentration LY29err from the time
course data as part of the parameter estimation problem. To this
end, the concentration of LY29 (eq. 3) was redefined posteriorly:
LY29 ½  ~u2,2zu2,3LY29err,u2,3~
0 : tv15 min
1 : otherwise
 
: ð8Þ
The parameter estimates obtained from a combined fit to the
traditional and the optimized experiment (Table 1) calibrated the
model in excellent agreement with data (Figure 2E). While the
estimate for LY29err clearly suggested that residual LY29 was
present, it did not significantly affect the large improvement of the
resulting parameter estimates (Figure 2C, green arrows; Table S1).
Table 1. Parameter estimates and their uncertainties.
Parameter after traditional after 1st optimized after 2nd optimized
p1 s1 p2 s2 p3 s3
w
 
min{1 1.88 4.10 5.23 11.91 1.80 1.95
a
 
min{1 0.23 0.18 0.16 0.03 0.11 0.03
KLY=mM 3.67 4.66 3:18|10{3 0.46 0.16 0.34
kr
 
mM{1min{1 6.09 33.45 1.03 0.85 1.56 1.33
kt
 
AU{1min{1 1.47 1.65 3.82 5.44 0.03 3.41
ka
 
AU{1min{1 0.59 0.96 1.24 2.71 0.58 0.52
residual 8.34 10.30 11.15
D-criterion
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
det C
6 p   
0.87 0.31 0.18
mean of variances 193.5 30.0 2.9
Parameter estimates and local approximations of their uncertainty after the traditional, the first optimized, and the second optimized experiment. Shown are the system
parameters which are believed to be identical from cell to cell: the degradation rate w of PIP3, the dissociation rate a for the dissociation of Akt from the plasma
membrane, the inhibitor constant KLY for LY29, and the association rates kr for the binding of iRap to the FKBP domain of CF-p85, kt for the formation of the trimeric
complex of CF-p85, iRap, and Lyn-FRB, and ka for the recruitment of Akt to the plasma membrane. pi and si denote the parameter estimate and its corresponding
uncertainty after the ith experiment was performed.
doi:10.1371/journal.pcbi.1000558.t001
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A practical limitation in live-cellimaging experiments isthat only a
limited number of buffer changes can be performed without exerting
cell stress. Instead of employing a fixed time-point model for adding
drugs, it could also be beneficial to optimize at which time points
drugs are added. We therefore derived a constraint formulation that
extends the previous approach by optimizing the time points of two
buffer changes in addition to their drug composition.
To this end, the system of ODEs was subjected to a time
transformation, by which the differentials were multiplied by a
piecewise constant control function t~u3,3 that was discretized
into the three segments of incubation. In this parameterization,
large values of t correspond to longer intervals between buffer
changes with more measurements, which was reflected by
transforming the error model accordingly to ~ s s&s=
ﬃﬃﬃ
t
p
.I n
addition, a dynamic constraint formulation was employed to
ensure that the duration of the optimized experiment would equal
to the duration of the established protocol:
ð24 min
0m i n
t t ðÞ dt~24 min: ð9Þ
Further, to facilitate the experiment, we limited the protocol to
drug additions (see Methods). This also reflects a protocol
Figure 2. Numerical optimization of experimental design and practical experimentation to infer model parameters from live-cell
microscopy data. (A) Schematic of sequential experimentation. The traditional design (left) resulted in a model that was used for optimizing the
concentration-time profile of iRap (green) and LY29 (pink) for the next experiment. (B) The washout of LY29 at minute 15 was realized by inserting a
needle connected to a vacuum trap, and rinsing with 5 ml of 1 mM iRap in extracellular buffer. (C) Mean of parameter variances predicted for or
achieved with the optimized experiment. Arrows indicate the parameter variance at different stages of model development, and under consideration
of experimental uncertainty introduced by the wash. (D) Confocal fluorescence images of an NIH 3T3 cell (CF-p85 shown in cyan, Y-PH in yellow).
30 nM iRap was added immediately before triggering time-lapse acquisition. After 5 min, 1 mM iRap and 8:7 mM LY29 were added. 10 min later, LY29
was washed out, using 1 mM iRap in extracellular buffer. Experiment time is shown in minutes. (E) Combined parameter estimation from both the
traditional (left) and optimized (right) experiment. Error bars show data, continuous lines show model output. Blue error bars and lines show cytosolic
fluorescence of CF-p85, orange error bars and lines cytosolic fluorescence of Y-PH. The frame captured at minute 15 of the optimized experiment was
lost to brightfield illumination during the washout procedure.
doi:10.1371/journal.pcbi.1000558.g002
Optimal Experimental Design
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dures are difficult to implement.
Under these constraints, experimental designs were optimized
for different design criteria (Figure 3A, 3B) based on the diagonal
elements, the maximum eigenvalue, and the determinant of C.
While for any experiment only small overall improvements of the
parameter estimates were predicted when compared to a
repetition of the established protocol, the three optimized designs
mostly aimed at the uncertainty of KLY. Such an opportunity for
narrowing down selectively a single parameter would have been
difficult to predict by intuition.
Sequential model refinement from live-cell data
In this specific situation, we used the determinant criterion
to optimize particularly for the inhibitor constant of LY29.
According to this second optimized protocol (Figure 3C), cells
were treated with 0:5 mM iRap for 10 min, eliciting fast
translocation of CF-p85. In the course of 10 min, membrane-
targeted CF-p85 stimulated the production of PIP3, as was
indicated by a decline of cytosolic fluorescence from Y-PH. The
concentration of iRap was then doubled with a concomitant
addition of 10 nM LY29. PI3K activity was largely insensitive to
such a low dose of inhibitor, thus establishing a lower bound for
Figure 3. Minimization of different uncertainty criteria under experimentally meaningful design constraints. Different uncertainty
criteria were minimized by finding optimal time points for adding drugs and optimal concentrations. Washouts were excluded from the design space
by a dynamic constraint formulation. (A) Performance comparison of different criteria with respect to parameter uncertainty or (B) the eigenvalue
spectrum of the optimized experimental design. Arrows indicate the eigenvalue that is aligned with the uncertainty of KLY. (C) Schematic of
sequential experimentation. The data from the traditional and the first optimized experiment were used for optimizing the concentration-time profile
of iRap (green) and LY29 (pink) for the next experiment. (D) NIH 3T3 cell (CF-p85 shown in cyan, Y-PH in yellow). 0:5 mM iRap was added at the
beginning of the experiment. 10 min later, another 10 nM LY29 and another 0:5 mM iRap were added. PI3K remained active as judged from low
cytosolic fluorescence of Y-PH. 25 mM LY29 was added at minute 20, resulting in dissociation of Y-PH from the plasma membrane. Time is shown in
minutes. (E) Combined parameter estimation on all three experiments. Error bars show data, continuous lines show model output. Blue error bars and
lines show cytosolic fluorescence of CF-p85, orange ones show cytosolic fluorescence of Y-PH.
doi:10.1371/journal.pcbi.1000558.g003
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dissociation of Y-PH (Figure 3D, Video S3).
Finally, we formulated the parameter estimation problem on the
data obtained from the traditional and both optimized experi-
ments. To obtain a satisfying collective fit for all three experiments,
we considered background fluorescence from CF-p85 and Y-PH
recruited to the plasma membrane and to internal membranes.
For simplicity, a fraction bi of bound CF-p85 and Y-PH was
included into the observation functions:
hYFP,i ti,j
  
~ PH ½  tot,i{ 1{bi ðÞ PH ½  mem,i ti,j
  
ð10Þ
hCFP,i ti,j
  
~ p85 ½  tot,i{ 1{bi ðÞ Lyn :: iRap :: p85 ½  i ti,j
  
, ð11Þ
Here the index i denotes the experiment number, ti,j the time
point tj in experiment i. With this assumption, parameter
estimation established good agreement between the model and
the measurements from all three experiments combined
(Figure 3E). Note that for bi~0, the revised observation functions
revert to equations (4) and (5).
Posterior assessment
To assess if optimal experimental design yielded data that
reasonably defined the parameters of the proposed PIP3 signaling
model, we approximated the uncertainties of parameter estimates
after each of the three experiments (Table 1). Overall, the mean of
variances dropped from 193 to 2.9 (Figure 4A), much faster than
one could expect from triplicate measurements. Most of this
decline reflects improvements of the parameter estimates with the
highest initial uncertainty, kr, w, and KLY. Moreover, the
parameters controlling downstream signaling, a and ka could be
inferred with much improved accuracy. From experiment to
experiment, however, the parameter estimates varied strongly, in
agreement with most relative uncertainties remaining above
100%. Nevertheless, we identified a protocol that renders all
endogenous parameters accessible in few single-cell experiments.
This protocol of three designs could be refined further by taking
advantage of the improved previous knowledge.
On the other hand, the uncertainty of the exogenous parameter
kt increased from the initial experiment to the final model because
it describes the association of CF-p85 to Lyn-FRB. Lyn-FRB is not
fluorescently tagged and is virtually unidentifiable with free bi
(Table S1). Consistently, kt is the least defined system parameter in
the final model (Figure 4B). Nevertheless, this uncertainty does not
propagate to endogenous parameters because the localization of
CF-p85 is observable. This is a favorable property because it
suggests that the exact transfection efficiency for Lyn-FRB is not
critical as long as it expresses much better than CF-p85.
In their study, Gutenkunst et al. used published intuitively
designed experimental protocols to characterize parameter iden-
tifiability in different models [6]. Independently of the size of these
models, they found that a substantial fraction of eigenvectors of the
uncertainty region ran along multiple axes in parameter space. The
eigenvectors of C computed after the intuitive experiment from
Figure 1 suggested a similar co-dependence also for this model
(Figure 4C). However, the data from a single numerically optimized
experiment largely eliminated the correlation between estimates.
The corresponding eigenvalue spectrum of C confirms that also the
extent of the uncertainty region was consistently reduced
(Figure 4D).
Discussion
An important goal of signal transduction research is to obtain
molecularly explicit mathematical models that describe the flow of
information. A particular challenge in obtaining such models is the
large number of poorly defined parameters. Here, we demonstrate
for the first time the use of an optimal control method to
Figure 4. Decline of uncertainty. (A) The mean of parameter variances dropped from 193.5 after the traditional experiment to 2.9 after the second
optimized one. For comparison, parameter uncertainties were calculated for repetitions of the intuitive traditional experiment. (B) Parameter
uncertainties after individual experiments were performed. (C) Normalized eigenvectors of the corresponding covariance matrices ordered in
ascending length suggest that correlation between biological parameters was largely eliminated. (D) The ranges of the eigenvalue spectra of C were
consistently reduced.
doi:10.1371/journal.pcbi.1000558.g004
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optimization of experimental designs. Our results suggest that
this approach relies on four main ingredients: (i) a carefully
parameterized dynamic model, (ii) quantitative measurements with
appropriate error assumptions, (iii) pharmacological perturbation
tools, (iv) and an experimental design space that is realistically
constrained. We show that an efficient numerical algorithm can
derive non-intuitive experimental designs that significantly reduce
the experimental effort to infer parameters of a dynamic model
with good statistical quality.
Using optimal experimental design for parameter
estimation in cell signaling
Our study focused on how an optimal control method can be
employed to interrogate a cell signaling system by live-cell
microscopy. The goal of this approach was to reveal biologically
relevant parameters of a model that describes the dynamic
behavior of the PIP3 lipid second messenger, the recruitment of a
cytosolic pleckstrin homology domain to the plasma membrane,
and the inhibition and activation of PI3K by means of
pharmacological and synthetic biology techniques. We found that
the data obtained from the established experimental protocol
resulted in large parameter variances and, in effect, inconclusive
estimates. However, the model was useful to inform an optimal
control method that proposed modifications of the existing
protocol to markedly reduce parameter uncertainty. While we
found that the appropriate parameterization of the design space is
important for the attainability of optimized concentration-time
profiles, experimental imperfection led only to a small reduction in
information gain (Figure 2C). On the other hand, the uncertainty
of parameter estimates appeared to be more important (Figure 2C),
suggesting that methods for robust optimal experimental design
will be of much practical value [15]. Importantly, not only
robustness to uncertainty of parameter estimates, but also to
uncertainty in model structure and experimentation will need to
be addressed more formally by future optimization methods, e.g.
along the developments described in [21].
Considering the specific model structure of the translocation
assay, the first optimized experiment at a first look did not seem
intuitive. However, it can be rationalized as an intelligent
maneuver to separate the translocation kinetics of CF-p85 from
the production of PIP3. To this end, a high concentration of iRap
was added in the presence of the inhibitor LY29, and then LY29
was washed out after CF-p85 was brought into position. By
employing a submaximal dose of LY29, the identifiability of the
inhibitor constant could be improved simultaneously. This
suggests that the first optimized experiment clearly exploited
features of the experimental system that were independent of
details in model structure and parameter values. Moreover, it is
interesting to note that for the last segment of the experiment, it
was not necessary to wash out LY29 completely. Our posterior
analysis that accounted for experimental imperfection suggests
that significant residual amounts of LY29 did not significantly
affect the realized design performance (Figure 2C).
The second optimized experiment employed novel dynamic
constraint formulations to optimize a limited number of buffer
changes and time points. These formulations could be of general
value for reflecting actual experimental constraints. With the
constrained design spaces used for optimizing the second
experiment, we were limited to three additions of drug. While
this design was clearly informative, its performance with respect to
parameter identifiability was sensitive to uncertainty of KLY. This
exemplifies a drawback of minimizing the determinant of the
covariance matrix. Since the determinant criterion aims at the
volume of the confidence ellipsoid (Figure 1G), an experimental
design that defines a single parameter value such as KLY very
tightly, would correspond to large improvements in the objective
function. In other words, minimizing det C in some cases focuses
experimental effort at eliminating a full dimension of the
uncertainty region (Figure 3B). Thus, despite the significant
improvement predicted for KLY, it should be noted that focusing
effort on a single parameter can be sensitive to overall uncertainty.
Enhancing the identifiability of endogenous parameters
by chemical biology
The practical non-identifiability of many parameters is an
important challenge for the development and use of signaling
models. Intuitively, this means that there are too many parameters
for the number and the type of experiments that can be practically
performed. Moreover, the structure of such models was suggested
to reflect natural robustness to changes in many parameter values
[3,6]. For example, signaling pathways often translate graded
stimuli into all-or-none responses [22], such that downstream
observations become insensitive to upstream kinetic parameters.
Strong covariance between parameters of reaction cascades, fast
reversible reactions, and binding events makes it difficult to
constrain single parameter values [3,6,10,23]. Therefore, phar-
macological and synthetic tools that drive a biological system
internally will become important for eliciting informative dynam-
ics. The pair of Lyn-FRB and CF-p85 is one example of such tools,
because endogenous PI3K is activated directly and downstream of
complex receptor relays. Likewise, the small molecule inhibitor of
PI3K that we employed exemplifies the value of pharmacological
tools in the context of such perturbation studies. In essence, our
work suggests that chemical tools may be useful for dividing
complex pathways into tractable signaling domains in order to
conquer non-identifiabilities in situ. However, it was not clear
intuitively how to combine these perturbations in order to
generate data from which parameters could be inferred. Our
work exemplifies that in such a situation, model-based experi-
mental design can dramatically reduce the experimental effort to
establish a useful protocol.
Challenges to parameter estimation in systems biology
To summarize, several issues should be considered when a
signaling system is explored using a dynamic model. First, it is
often difficult to develop comprehensive cell signaling models that
are simple enough to be useful but that do retain enough detail to
represent the essential features of a system quantitatively. Finding
a trade-off between overparameterized model formulations and
formulations that neglect important interactions is made difficult
by our limited knowledge of the mammalian signaling network
and by often large uncertainties in measurements. Second, our
study suggests that pharmacological perturbations are powerful
tools to enhance the quality of parameter estimates. We show that
when such pharmacological agents are not available, synthetic
biology approaches can be employed. In all those cases, numerical
methods for optimal experimental design can propose protocols
that take advantage of these experimental techniques. Third, the
experimental design space should be constrained during optimi-
zation to result in feasible protocols. This ensures that the
experiment can be realized according to the proposed plan. At the
same time, our results suggest that some experimental protocols
can be robust to imperfection (Figure 2C). Our approach to reveal
parameter values of biological models complements other
approaches of optimal experimental design in systems biology,
such as designing experiments for model discrimination [24] or for
minimizing prediction uncertainty [25].
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assays
Ideally, the parameter values of a biochemical model corre-
spond to biologically meaningful properties. In our example, w
reflects the degradation rate of PIP3, ka and a describe the affinity
of a PH domain, and KLY reflects the inhibitor constant of LY29.
Because any model can only be an approximation of the true
process in nature, the parameter values we determine are model-
specific. Nevertheless, if such parameters could be inferred with
sufficient accuracy, they may reflect molecular differences that
underlie biochemical mechanisms. We could envision that in a
pharmacological context, drug candidates for targeting PI3K
could be compared in situ by inferring KLY from few single-cell
experiments. Likewise, in a biochemical context, differences in PH
domain affinities could be revealed by estimating a. Finally, w
reflects the activity of phosphatases like phosphatase and tensin
homolog (PTEN) which is lost in many cancers [26]. Importantly,
inferring w in cell lines established from cancer patients could
reveal changes in PTEN activity that originate from causes beyond
gene expression. To achieve this, instead of minimizing a criterion
on the full covariance matrix (e.g. the trace or determinant),
experimental effort could focus only on the subset of diagonal
elements of interest. Applications of such an approach may include
a comprehensive estimation of signaling parameters from cancer
samples, possibly leading to individualized therapy. Also, by
treating drug action as a systems property, this approach may also
be useful to evaluate possible off-target effects of drugs.
Conclusion
We showed here for the first time that optimal experimental
design for parameter estimation yields rich data for rapid model
development in systems biology. This approach aims to restrict the
range of possible parameter values, and is therefore a suitable way
to challenge the validity of a model by quantitative experimen-
tation. In particular, the results exemplify the use of this optimal
control method to interrogate individual cells for pharmacological
and biological parameters that underlie a growth-related second
messenger signaling system.
Materials and Methods
Cell culture, constructs, and drugs. 4-well LabTek
chambered coverslips (nunc, Rochester, NY) were coated with
0.1 mg/ml poly-L-lysine (Sigma-Aldrich, St. Louis, MO) in
hydroborate buffer. 2|104 NIH 3T3 cells were seeded per well,
and grown close to confluency. Per well (1:8c m 2), 0:5 mg of each
construct (Lyn-FRB, CF-p85, Y-PH) were transfected using 1:8 ml
Lipofectapine 2000 in 50 ml total transfection mix on 350 ml
DMEM supplemented with 10% FBS for 6 hrs (all reagents from
Invitrogen, Carlsbad, CA). 4 to 12 hours prior to imaging, cells
were serum-starved in 0.1% BSA (Sigma-Aldrich) in DMEM. CF-
p85 is described in [17], and Lyn-FRB (as Lyn11{linker{FRB)
in [27]. Stock solutions of LY294002 (Tocris Bioscience, Ellisville,
MO) and iRap were prepared in DMSO. For the organic synthesis
of iRap from rapamycin and 3-methylindole, see [27].
Numerical methods. The numerical methods used are
incorporated in the software package VPLAN [7,8]. They include
a variable–step variable–order BDF method for initial value
problems in differential equations, which is used for the simulation
of the translocation model. This solver is based on [28,29] and
computes first and second derivatives of the solution of the initial
value problem with respect to initial values and parameters,
utilizing a sophisticated combination of internal numerical
differentiation [30] and automatic differentiation [31]. Parameters
in the translocation model were estimated using a multiple
shooting method with a generalized Gauss-Newton algorithm that
is implemented in PARFIT (see [30,32], reviewed in [33]).
Multiple shooting methods consider the parameter estimation
problem as a least squares problem that is constrained by a
differential equation model. The differential model constraint is
discretized like a boundary value problem. This enhances stability
of the method and allows for initialization of the discretized output
trajectories close to measurement data, which results in fast
convergence to statistically stable minima. In contrast, single
shooting methods only solve the initial value problem from the
beginning of an experiment, and integrate with possibly poor
initial guesses for parameter values along the full time axis. If at all
feasible, a solution is found only with much more effort than by
multiple shooting. Recently, Balsa-Canto et al. proposed a hybrid
approach that switches from a global search to a multiple shooting
Newton-type method [34]. Optimal experimental designs are
determined by minimizing a function of the covariance matrix of
the parameter estimation problem (e.g. the sum of the diagonal
elements) with respect to the concentration-time profile of drugs
and possibly the sampling scheme. The method is applicable to
constrained parameter estimation problems in systems of differ-
ential algebraic equations (DAE). In the general case of
constrained problems, the covariance matrix C can be represented
in terms of J1~J (see eq. 7) and the sensitivities J2 of the
constraints:
C~ I 0 ½ 
JT
1 J1 JT
2
J2 0
   {1 JT
1 J1 0
00
  
JT
1 J1 JT
2
J2 0
   {T I
0
  
:ð12Þ
To exclude washout procedures in the second optimized
experiment, we defined a differential state variable xk as a
‘‘short-term memory’’ for each drug, and defined diffusion-like
equilibration with the current concentration u3,k t ðÞ :
dxk
dt
~Du 3,k t ðÞ {xk t ðÞ ðÞ ð13Þ
By introducing the dynamic inequality constraint u3,k t ðÞ {xk t ðÞ §0
which needs to be evaluated only once after each buffer change, we
can approximate a constraint of the form u3,k ^ t t ðÞ §u3,k   t t ðÞfor ^ t t§  t t.
The constraint is stricter the larger one choses D. In our specific
case, D~1 min {1 was sufficient. These constrained optimal
control problems were solved by a direct approach for optimal
control, the core of which is solving a structured nonlinear program
by SQP-type methods [20]. All calculations were performed on a
Dell Optiplex GX620 workstation.
Live cell microscopy. Cells were imaged at 220C using a
UApo/340 40x/1.35 oil objective (Olympus, Center Valley, PA)
mounted on an Olympus IX70 stage customly equipped with an
UltraVIEW spinning disk confocal scanner (PerkinElmer, Wal-
tham, MA). CF-p85 and Y-PH were excited with a He-Cd laser
(IK series from Kimmon, Centennial, CO) or an Ar laser (model
60B from ALC, Salt Lake City, UT), using 442/10 or 515/10
excitation filters, and 480/40 or 530LP emmission filters,
respectively. The variable power supply of the Ar laser was taped
at the beginning of this study, and the power of each laser was
measured on stage through an Olympus UPlanFl 10x/0.30
objective before every experiment using an optical power meter
(model 835 from Newport, Irvine, CA) to safeguard quantitative
analysis. Images were captured from a Hamamatsu C4742 Orca
(Hamamatsu Photonics, Shizuoka, JP) at 12 bit/pixel and
300 msec exposure time. Shutters were emulated using a closed
Optimal Experimental Design
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Lambda 10–2 (Sutter Instrument Company, Novato, CA).
Extracellular buffer contained 5 mM KCl, 125 mM NaCl,
1.5 mM CaCl2, 1.5 mM MgCl2, 10 mM D-glucose (Sigma-
Aldrich), and 20 mM HEPES (Invotrogen).
Image analysis. For each experiment, an empty region of the
coverslip was captured in both fluorescence channels, and used for
background subtraction. Image stacks were aligned with subpixel
resolution to compensate for planar drift where needed.
Fluorescence was quantified using the median of a region of
25|25 pixels, that was chosen to minimize interference from
passing organelles, and that is marked by green squares in
Figures 1B, 2D, and 3D. The standard deviation of measurements
s was obtained from the standard deviation of intensities in the
region of 25|25 pixels for each frame. For optimizing designs, we
assumed a constant error model, however with larger errors for
CF-p85 (0.2 AU) than for Y-PH (0.06 AU).
Supporting Information
Table S1 Estimates for calibration parameters.
Found at: doi:10.1371/journal.pcbi.1000558.s001 (0.11 MB XLS)
Text S1 Model represented in SBML layer 2 version 2, featuring
two compartments (the cytosol and the plasma mebrane) and all
molecular species, including iRap and LY29. The parameter
values are set to the estimates from the collective fit to all data.
Found at: doi:10.1371/journal.pcbi.1000558.s002 (0.01 MB
XML)
Video S1 Initial Experiment
Found at: doi:10.1371/journal.pcbi.1000558.s003 (0.89 MB
MOV)
Video S2 First optimized experiment
Found at: doi:10.1371/journal.pcbi.1000558.s004 (1.00 MB
MOV)
Video S3 Second optimized experiment
Found at: doi:10.1371/journal.pcbi.1000558.s005 (1.32 MB
MOV)
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